Nansa Burlet is a qualified MD with master’s degrees in public health and business administration.
Nansa started her career as a Science Director at the International Osteoporosis Foundation. She was in charge of designing and implementing disease awareness projects and patient support programs in multi-cultural environments.
She then moved to preventative healthcare and acquired a solid experience in medical affairs in the vaccine field. She successfully launched several global vaccines including those for HPV, zoster, and dengue at SMPSD, GSK and Sanofi Pasteur, respectively.
As a passionate healthcare professional with special interest in new technologies and a dedication to patients’ health outcomes, she then took over a global position as Head Patient Insights Innovation at Sanofi, where she took part in projects focused on behavioral sciences, artificial intelligence, and patient experience.
She recently joined Kyowa Kirin International as the Patient Partnership Lead. Her ambition is to collaborate with patients to design clinically relevant and convenient treatments, with the ultimate goal of empowering patients to better manage their own condition.